Antonio Wolff

Professor of Oncology

Johns Hopkins University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Antonio Wolff is a Professor of Oncology at Johns Hopkins University, USA. His research focuses on improving clinical trial participation, developing genomic tests for breast cancer, and evaluating mindfulness interventions for cancer survivors. He has contributed significantly to guidelines for HER2 testing in breast cancer and has published extensively on treatment strategies for early-stage and metastatic breast cancer.

Articles (16)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Vice Chair/ Professor

Emory University

UNITED STATES

View details

Catherine Crespi

Professor

University of California Los Angeles Jonathan and Karin Fielding School of Public Health

UNITED STATES

View details

Nicole E Caston

The University of Alabama

UNITED STATES

View details

Patricia Ganz

Professor

University of California, Los Angeles

UNITED STATES

View details

Kala Visvanathan

Professor

Johns Hopkins University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antonio Wolff

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

System-Level Transformations to Increase Patient Participation in Clinical Trials

Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 study

Moderators of Intervention Efficacy in the Pathways to Wellness Trial of Survivorship Education and Mindfulness Meditation for Younger Breast Cancer Survivors

HER2DX genomic test in early-stage HER2-positive breast cancer

Mediators of a Mindfulness-Based Intervention for Younger Breast Cancer Survivors: Effects on Depressive Symptoms

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update

Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer and Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A

Flashback Foreword: Multigene Predictor for Chemotherapy Response in Breast Cancer

Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials

Racial and ethnic disparities in mortality among breast cancer survivors after a second malignancy

Antibody-Drug Conjugates in Breast Cancer: Searching for Magic Bullets

Evaluation of Predict, a prognostic risk tool, after diagnosis of a second breast cancer

Adjuvant Abemaciclib Plus Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A

Reply to I. Jatoi

Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer

Collaborators (12)

Courtney P. Williams

Robert Miller

Lisa Anne Carey

Eileen Shinn

Joseph A. Sparano

Jean L. Wright

Habib Rahbar

Sunil Badve

Catherine Crespi

Nicole E Caston

Patricia Ganz

Kala Visvanathan

Make your next move.